Yahoo Finance1mon
PaxMedica Announces First Patent Allowance for Suramin Intranasal Formulation in the treatment of Autism Spectrum Disorder and Other Conditions
This patent covers claims for treating neurological disorders, such as autism, using a novel formulation of suramin for intranasal delivery, rather than its current infusion dosing. Similar patent ...
PharmiWeb1mon
PaxMedica Announces First Patent Allowance for Suramin Intranasal Formulation in the treatment of Autism Spectrum Disorder and Other Conditions
This patent covers claims for treating neurological disorders, such as autism, using a novel formulation of suramin for intranasal delivery, rather than its current infusion dosing. Similar patent ...